Stay updated with breaking news from Arya Sciences Acquisition Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The slow pace of financing in med-tech appears to have stimulated cardiac arrhythmia technology developer Adagio Medical Inc. to turn to a special purpose acquisition company (SPAC) in a type of deal that has all but vanished in the last year. The company signed an agreement with Arya Sciences Acquisition Corp. IV to combine in a reverse merger deal that will result in Adagio’s listing on Nasdaq under “ADGM.”
Arya Sciences Acquisition Corp IV agreed to a business combination with Adagio Medical, taking the cardiac ablation company public.
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Free Report) and Rigetti Computing (NASDAQ:RGTI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations. Insider & Institutional Ownership […]
ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD – Get Free Report) fell 0.4% on Tuesday . The company traded as low as $10.81 and last traded at $10.81. 80,101 shares were traded during mid-day trading, an increase of 7% from the average session volume of 75,025 shares. The stock had previously closed at $10.85. ARYA Sciences […]
These are the stocks posting the largest moves in midday trading.